Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy

Completed

• Conditions: Renal Hematoma; Urolithiasis
• Interventions: Drug: low molecular weight heparin; Drug: Acetylsalicylic acid

• Registration Number: NCT02875717
• Lead Sponsor: Kantonsspital Winterthur KSW

Brief Summary

Retrospective Analysis of patients that received shockwave lithotripsy as Treatment of ureteral or kidney Stones. Condition examinated is the effect of low molecular weight Heparins and acetylsalicylic acid on the Formation of renal hematoma after shockwave lithotripsy. Primary outcome is documented hematoma in a postoperative ultrasound control. Secondary outcomes are perioperative complication, Need for erythrocyte tranfusion, interventions for bleeding control, readmission or death within 30 days.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-01
• Primary Completion: 2015-09
• Study Completion: 2015-09
• Status Verified: 2016-08
• Study First Submitted: 2016-08-18
• Study First Submitted QC: 2016-08-18
• Last Update Submitted: 2016-08-18
• Study First Posted: 2016-08-23
• Last Update Posted: 2016-08-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• consent
• Stones in kidney and proximal Ureter
• Treatment with shockwave lithotripsy for urolithiasis between January 2009 and September 2015 at Kantonsspital Winterthur

Exclusion Criteria

• other Position of ureteral Stones
• missing data in Patient reports
• refused consent
• under Age limit

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Low Molecular weight heparin	low molecular weight heparin	Patients that were on medication with low molecular heparin on the date of shockwave lithotripsy
Acetylsalicylic acid	Acetylsalicylic acid	Patients that were on medication with Acetylsalicylic acid on the date of shockwave lithotripsy

Primary Outcome Measures

Name	Time	Method
Renal Hematoma in ultrasound control	first day after intervention

Secondary Outcome Measures

Name	Time	Method
Need for erythrocyte concentrate tranfusion	30 days after intervention
Intervention for bleeding control	30 days after intervention
Hospital readmission	30 days after intervention
Death	30 days after intervention

Trial Locations

Locations (1)

Kantonsspital Winterthur; 🇨🇭 Winterhur, Kanton Zürich, Switzerland